drugset / Trial / NCT06775093

Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

NCT06775093

Not yet recruiting 392 enrolled Peking University Third Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to examine whether benalutide combined with metformin and healthy lifestyle education in women with PCOS and obesity prior to fertility treatment improves live birth rate and other reproductive, maternal and perinatal outcomes compared to metformin plus healthy lifestyle education.

Timeline

Start
2025-03-01
Primary completion
2026-12-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Benaglutide Unknown 0.2 mg Subcutaneous
Background Metformin Small molecule 0.5 g